Do seasonals shine a light on Illumina (ILMN Stock)? [Video]
|Illumina, Inc. is an American biotech company with its headquarters in San Diego, California. It is a health tech company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
On Tuesday after the close, Illumina will report its earnings. Historically the stock tends to gain over this period of time with a 73% win percentage between February 3 and February 15. So, does this mean that Illumina will repeat its seasonal pattern again this year? Or will earnings disappoint and send the stock lower?
Major Trade Risks: The major trade risk here is that the seasonal pattern does not repeat itself again this year.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.